IDNA ETF (iShares Genomics Immunology and Healthcare ETF) is managed by iShares by BlackRock (US) with $201.1M in net assets. IDNA expense ratio is 0.47%, holding 78 positions across sectors including Health Care, Unknown, Industrials. Inception date: 2019-06-11.

IDNA performance shows a YTD return of 22.68%. The 1-year return is 63.80% and the 5-year return is -7.75%. IDNA dividend yield stands at 0.83%, paid semi-annually.

IDNA top holdings include Revolution Medicines Inc Ser C Pc Pp (6.9%), Moderna therapeutics (6.3%), Ipsen Sa (5.2%), Takeda Pharmaceutical Co Ltd (4.5%), Bayer Ag (4.4%). View all IDNA holdings, sector breakdown, or dividend history.

IDNA can be compared against other funds using the overlap calculator or side-by-side comparison tool. IDNA alternatives are available via the screener, along with tax-loss harvesting opportunities.